Hereditary Cancer in Clinical Practice

Titel Veröffentlichungsdatum Sprache Zitate
Identification of new genetic alterations in MLH1, MSH2 and MSH6 using IHC and HRM analysis in Lynch syndrome-suspected patients2012/01/01English
A case of late breast cancer metastases to both suprarenal glands 28 years after mastectomy2012/01/01English
The case of the youngest infant with hepatoblastoma with APC gene mutation2012/01/01English
Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment2012/01/01English
Prospective clinical trials on correlations between macro-/ microelements and vitamins and cancer risk2012/01/01English
Selenium and the risk of cancers of the colon, pancreas and stomach2012/01/01English
Selenium and risk of bladder cancer2012/01/01English
CHEK2 mutations as markers for high risk of breast cancer2012/01/01English
DNA methylation in tumor-adjacent normal tissue in the course of head and neck squamous cell carcinoma as an epigenetic field for cancerization2012/01/01English
Effects of X-ray irradiation on methylation levels of p16, MGMT and APC genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa2012/01/01English
Mutations and polymorphisms of genes moderate increase in gastric cancer risk2012/01/01English
Fast diagnostic test for the identification of an increased genetic predisposition to colon cancer (exemplified on a DNA test for recurrent mutations of the gene MMR)2012/01/01English
Why choose the treatment with cisplatin for BRCA1 breast cancers patients?2012/01/01English
Artificial neural network in predicting bladder cancer recurrence2012/01/01English
BRCA1 mutation- oncological treatment- reconstructive surgery of the breast- pregnancy: diagnostic and therapeutic procedures in a 28 year old patient diagnosed with a tumor in the left breast with a BRCA1 mutation2012/01/01English
The CHEK 2 GENE mutations and the risk of Gastric cancer2012/01/01English
Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland2012/01/01English
Selenium and genotypes as marker of risk in BRCA1 mutation carriers2012/01/01English
Rapid test for detection of high risk of breast cancer2012/01/01English
DNA testing for high risk of prostate cancer2012/01/01English
The A148T variant of CDKN2A gene in bladder cancer2011/01/01English
New diagnostic test for high risk of breast cancer in Poland2011/01/01English
Clinical genetics of melanoma2011/01/01English
Participation of miRNA in conditioning the incidence and modification of the course of FAP2011/01/01English
Identification of new genes associated with breast and ovarian cancer risk. Advances of BCAC, CIMBA and OCAC2011/01/01English
Constitutional mutations of cancer susceptibility genes in the health workers professionally exposed to cytostatic drugs2011/01/01English
Allel RET+3 : T a medullary thyroid cancer2011/01/01English
Combined iPLEX and TaqMan assays to screen for 45 common mutations in Lynch syndrome and FAP patients2011/01/01English
Progress in clinical genetics of prostate cancer2011/01/01English
DNA bank for Polish patients with predispositions to occurrence of colorectal polyposis2011/01/01English